Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.

about

Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus.

P2860

Q55426855-3A032642-60F1-4764-9A9A-D11617C8D1A1

P2860

Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q52884927

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@en

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@nl

type

Item

label

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@en

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@nl

prefLabel

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@en

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@nl

P1476

Limited benefit of targeted mo ...... ted with renal cell carcinoma.

@en

P2093

Hironori Fukuda

http://www.w3.org/2001/XMLSchema#string

Jumpei Iizuka

http://www.w3.org/2001/XMLSchema#string

Kazunari Tanabe

http://www.w3.org/2001/XMLSchema#string

Toshio Takagi

http://www.w3.org/2001/XMLSchema#string

Tsunenori Kondo

http://www.w3.org/2001/XMLSchema#string

Yoji Nagashima

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted therapy for advanced renal cell carcinoma

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.

Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome.

Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.

Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.

Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects.

Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.

Surgical management and prognosis of renal cell carcinoma invading the vena cava.

Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib.

P2888

s10147-017-1119-9

P304

767-773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-017-1119-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28365808

http://www.w3.org/2001/XMLSchema#string

Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.

about

P2860

P2860

Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698